Form 4: CYH CFO Johnson's Equity Transactions

Community Health Systems' EVP & CFO Jason K. Johnson reported significant equity transactions, including vesting of performance shares and new grants of restricted stock and stock options.

Summary

• Jason K. Johnson, EVP & CFO of Community Health Systems Inc. (CYH), reported multiple equity transactions on March 1, 2026, under a Rule 10b5-1(c) plan.
• 30,000 performance-based restricted shares from the 2023-2025 performance period vested at 100% of the target, converting to common stock.
• 90,000 shares of time-vesting restricted stock were granted, which will lapse in one-third increments annually on the first, second, and third anniversaries of the grant date.
• 23,610 shares of common stock were disposed of at $3.46 per share, likely to cover tax liabilities related to the vesting and acquisition of shares.
• A new grant of 180,000 performance-based restricted shares was made for the 2026-2028 performance period, with vesting contingent on Cumulative Same-Store Adjusted EBITDA Growth (40%), Cumulative Same-Store Net Revenue Growth (40%), and Total Shareholder Return (TSR) Percentile Rank (20%). Vesting can range from 0% to 200% of the target on the third anniversary of the grant.
• 90,000 stock options with an exercise price of $3.46 were granted, vesting in one-third increments annually over three years, with an expiration date of February 29, 2036.
• Following these transactions, Johnson beneficially owns 268,439 shares of common stock directly.
• Johnson also holds various derivative securities, including 180,000 performance-based restricted shares for the 2026-2028 period, 30,000 for 2024-2026, 30,000 for 2025-2027, and a total of 238,000 stock options with varying exercise prices and expiration dates.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it indicates the successful achievement of past performance targets, leading to the vesting of executive equity, and the continued alignment of executive incentives with future company performance through new equity grants. The disposition of shares for tax purposes is a routine event.

Positives

• 30,000 performance-based restricted shares vested at 100% of the target, indicating successful achievement of performance objectives for the 2023-2025 period.
• New grants of 90,000 time-vesting restricted shares and 180,000 performance-based restricted shares demonstrate continued long-term incentive alignment with company performance.
• A new grant of 90,000 stock options provides additional potential upside for the executive.

Negatives

• The disposition of 23,610 shares of common stock at $3.46, likely for tax withholding, reduces the executive's direct common stock holdings.

Risks

• The vesting of performance-based restricted shares for the 2026-2028, 2024-2026, and 2025-2027 periods is subject to the Issuer's attainment of specific performance objectives, meaning the actual number of shares that will ultimately vest could range from 0% to 200% of the target.
• The value of stock options and restricted stock is subject to the future performance of Community Health Systems' stock price.

Future Outlook

The company's executive compensation structure includes forward-looking performance objectives for restricted share vesting, tied to Cumulative Same-Store Adjusted EBITDA Growth, Cumulative Same-Store Net Revenue Growth, and Total Shareholder Return (TSR) Percentile Rank for the 2026-2028, 2024-2026, and 2025-2027 performance periods. The actual number of shares vesting will depend on the achievement of these targets, ranging from 0% to 200% of the target.

Industry Context

StockSavvy.ai notes that executive equity compensation, particularly through performance-based restricted shares and stock options, is a standard practice in the healthcare services industry. This structure aims to align executive incentives with long-term shareholder value creation and operational performance, such as same-store revenue and EBITDA growth, which are key metrics for hospital operators like Community Health Systems.

Related Party Transactions

• The transactions involve equity awards granted by Community Health Systems Inc. to its EVP & CFO, Jason K. Johnson, which are considered related party transactions as part of executive compensation.

Stakeholder Impact

• Shareholders: The vesting of performance-based shares and new equity grants align executive incentives with shareholder interests, potentially encouraging management to drive company performance. The disposition of shares for tax purposes has a minor dilutive effect but is standard.

Next Steps

• The time-vesting restricted stock granted on March 1, 2026, will lapse in 1/3 increments on the first, second, and third anniversaries of the grant date.
• The performance-based restricted shares granted for the 2026-2028, 2024-2026, and 2025-2027 performance periods will vest on the third anniversary of their respective grant dates, subject to the attainment of predetermined performance objectives.
• The stock options granted on March 1, 2026, will vest in 1/3 increments on the first, second, and third anniversaries of the grant date.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, including the vesting of previously earned performance shares and the grant of new equity awards, along with a tax-related disposition. While the 100% vesting of performance shares for the 2023-2025 period is a positive indicator of past performance, these are expected events under an existing compensation plan. The filing does not introduce new fundamental information about the company's operational or financial health that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting broader financial and operational updates.

Keywords

Community Health Systems, CYH, Jason K. Johnson, EVP & CFO, SEC Form 4, Insider Trading, Stock Options, Restricted Stock, Performance Shares, Equity Compensation, Executive Compensation, Share Ownership